Integrated analysis underlines etanercept efficacy in psoriasis


Washington - Results of a multistudy analysis reinforce the efficacy of subcutaneous etanercept (Enbrel, Amgen) for inducing rapid and sustained improvement in patients with chronic plaque psoriasis, said Kenneth Gordon, M.D., at the annual meeting of the American Academy of Dermatology.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.